 Paul Roberson
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TOR Serine-Threonine Kinases | 1 | 2022 | 454 | 0.590 |
Why?
| | Osteoblasts | 9 | 2014 | 145 | 0.410 |
Why?
| | Signal Transduction | 4 | 2022 | 5216 | 0.330 |
Why?
| | Whey Proteins | 2 | 2020 | 9 | 0.300 |
Why?
| | Physical Conditioning, Human | 2 | 2020 | 38 | 0.290 |
Why?
| | Dietary Carbohydrates | 2 | 2020 | 147 | 0.280 |
Why?
| | Bone and Bones | 4 | 2020 | 317 | 0.280 |
Why?
| | Osteogenesis | 7 | 2020 | 204 | 0.260 |
Why?
| | Apoptosis | 9 | 2014 | 2440 | 0.250 |
Why?
| | Ovariectomy | 4 | 2024 | 166 | 0.240 |
Why?
| | Osteocytes | 3 | 2014 | 24 | 0.220 |
Why?
| | Dietary Supplements | 2 | 2020 | 583 | 0.220 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 211 | 0.200 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.190 |
Why?
| | Rats, Wistar | 1 | 2024 | 450 | 0.190 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 266 | 0.180 |
Why?
| | Estradiol | 3 | 2024 | 515 | 0.180 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.180 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 138 | 0.180 |
Why?
| | Military Personnel | 2 | 2020 | 737 | 0.170 |
Why?
| | Estrogen Receptor alpha | 3 | 2013 | 151 | 0.170 |
Why?
| | HEK293 Cells | 1 | 2022 | 741 | 0.160 |
Why?
| | Atrophy | 2 | 2018 | 199 | 0.150 |
Why?
| | Rats | 4 | 2024 | 5584 | 0.150 |
Why?
| | Androgens | 3 | 2018 | 181 | 0.150 |
Why?
| | Body Composition | 2 | 2024 | 693 | 0.140 |
Why?
| | Osteoclasts | 5 | 2013 | 54 | 0.140 |
Why?
| | Nutritive Value | 1 | 2018 | 41 | 0.140 |
Why?
| | Bone Remodeling | 4 | 2014 | 71 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2024 | 935 | 0.130 |
Why?
| | Glucose | 1 | 2022 | 1048 | 0.130 |
Why?
| | Physical Fitness | 1 | 2018 | 207 | 0.130 |
Why?
| | Parathyroid Hormone | 2 | 2008 | 114 | 0.110 |
Why?
| | Bone Density | 6 | 2020 | 487 | 0.110 |
Why?
| | Estrogens | 4 | 2010 | 367 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 652 | 0.110 |
Why?
| | Cannabis | 1 | 2021 | 509 | 0.100 |
Why?
| | Oxidative Stress | 3 | 2013 | 1356 | 0.100 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 14 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2014 | 53 | 0.100 |
Why?
| | Animals | 15 | 2024 | 38030 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 910 | 0.100 |
Why?
| | Prednisolone | 2 | 2011 | 67 | 0.090 |
Why?
| | Alendronate | 3 | 2009 | 14 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 207 | 0.090 |
Why?
| | Osteoprotegerin | 1 | 2011 | 22 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2013 | 588 | 0.080 |
Why?
| | Aging | 2 | 2014 | 1969 | 0.080 |
Why?
| | Periosteum | 1 | 2008 | 14 | 0.070 |
Why?
| | Receptors, Androgen | 2 | 2018 | 148 | 0.070 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 82 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1789 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2020 | 2062 | 0.060 |
Why?
| | Mitosis | 1 | 2008 | 193 | 0.060 |
Why?
| | Femur | 3 | 2014 | 254 | 0.060 |
Why?
| | Glucocorticoids | 1 | 2011 | 531 | 0.060 |
Why?
| | Organ Size | 3 | 2018 | 461 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2007 | 143 | 0.060 |
Why?
| | Bone Resorption | 3 | 2020 | 81 | 0.060 |
Why?
| | Mice | 11 | 2014 | 18329 | 0.060 |
Why?
| | Stem Cells | 3 | 2013 | 628 | 0.060 |
Why?
| | Cell Differentiation | 3 | 2010 | 2046 | 0.050 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.050 |
Why?
| | Calcium | 3 | 2020 | 1190 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2003 | 65 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2003 | 78 | 0.050 |
Why?
| | Ovary | 1 | 2024 | 233 | 0.040 |
Why?
| | Body Weight | 2 | 2024 | 971 | 0.040 |
Why?
| | Adiposity | 2 | 2018 | 532 | 0.040 |
Why?
| | Transcription Factors | 2 | 2013 | 1734 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 441 | 0.040 |
Why?
| | Cells, Cultured | 4 | 2013 | 4148 | 0.040 |
Why?
| | Female | 13 | 2024 | 78844 | 0.040 |
Why?
| | Humans | 10 | 2022 | 145474 | 0.040 |
Why?
| | Calcitonin | 1 | 1999 | 27 | 0.040 |
Why?
| | Diphosphonates | 1 | 1999 | 68 | 0.040 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 5983 | 0.040 |
Why?
| | Phosphorylation | 3 | 2010 | 1707 | 0.040 |
Why?
| | Trenbolone Acetate | 1 | 2018 | 9 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 24 | 0.030 |
Why?
| | Cyclins | 1 | 1998 | 79 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2001 | 401 | 0.030 |
Why?
| | Orchiectomy | 1 | 2018 | 72 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2018 | 268 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1038 | 0.030 |
Why?
| | Testosterone | 2 | 2018 | 416 | 0.030 |
Why?
| | Physical Endurance | 1 | 2018 | 279 | 0.030 |
Why?
| | Vitamin D | 1 | 2020 | 403 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 1998 | 321 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2018 | 212 | 0.030 |
Why?
| | Time Factors | 3 | 2018 | 7123 | 0.030 |
Why?
| | Steroid 16-alpha-Hydroxylase | 1 | 1996 | 1 | 0.030 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1996 | 45 | 0.030 |
Why?
| | Nutritional Status | 1 | 2018 | 353 | 0.030 |
Why?
| | Lead | 1 | 1996 | 71 | 0.030 |
Why?
| | Muscle Strength | 1 | 2018 | 332 | 0.030 |
Why?
| | Up-Regulation | 1 | 1998 | 847 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1896 | 0.030 |
Why?
| | Male | 8 | 2020 | 72842 | 0.030 |
Why?
| | Reproduction | 1 | 1996 | 208 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1472 | 0.030 |
Why?
| | Interleukin-6 | 1 | 1998 | 776 | 0.030 |
Why?
| | Maternal Exposure | 1 | 1996 | 189 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2013 | 7 | 0.020 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3623 | 0.020 |
Why?
| | Forkhead Box Protein O3 | 1 | 2013 | 18 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 84 | 0.020 |
Why?
| | Forkhead Box Protein O1 | 1 | 2013 | 35 | 0.020 |
Why?
| | Adipogenesis | 1 | 2013 | 56 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 119 | 0.020 |
Why?
| | Young Adult | 2 | 2020 | 14218 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 306 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3747 | 0.020 |
Why?
| | Uterus | 1 | 2013 | 227 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 54 | 0.020 |
Why?
| | Spine | 1 | 2013 | 182 | 0.020 |
Why?
| | Cell Line | 2 | 2011 | 2823 | 0.020 |
Why?
| | HeLa Cells | 2 | 2003 | 632 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2010 | 1454 | 0.020 |
Why?
| | Pregnancy | 2 | 2021 | 7202 | 0.020 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2010 | 10 | 0.020 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 2010 | 10 | 0.020 |
Why?
| | Smad1 Protein | 1 | 2010 | 17 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 611 | 0.020 |
Why?
| | Glutathione Reductase | 1 | 2010 | 24 | 0.020 |
Why?
| | Adult | 3 | 2021 | 40777 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 61 | 0.020 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 76 | 0.020 |
Why?
| | Homeostasis | 1 | 2014 | 642 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 174 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 630 | 0.020 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2009 | 5 | 0.020 |
Why?
| | Acid Phosphatase | 1 | 2009 | 14 | 0.020 |
Why?
| | Thymidine Kinase | 1 | 2008 | 16 | 0.020 |
Why?
| | Models, Biological | 2 | 2008 | 1764 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4295 | 0.020 |
Why?
| | Ganciclovir | 1 | 2008 | 53 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 762 | 0.020 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 499 | 0.020 |
Why?
| | Isoenzymes | 1 | 2009 | 294 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 319 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2188 | 0.020 |
Why?
| | Collagen Type I | 1 | 2008 | 143 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10077 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10885 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 249 | 0.020 |
Why?
| | Postmenopause | 1 | 2009 | 392 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 845 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2507 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1082 | 0.010 |
Why?
| | Phenotype | 1 | 2013 | 3155 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2028 | 0.010 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 9 | 0.010 |
Why?
| | bcl-Associated Death Protein | 1 | 2003 | 10 | 0.010 |
Why?
| | Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| | RANK Ligand | 1 | 2003 | 27 | 0.010 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 45 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 550 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2003 | 112 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2003 | 2803 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 17291 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 125 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 146 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2003 | 155 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 239 | 0.010 |
Why?
| | Child | 1 | 2021 | 22707 | 0.010 |
Why?
| | Aged | 1 | 2021 | 26153 | 0.010 |
Why?
| | src Homology Domains | 1 | 2001 | 35 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1179 | 0.010 |
Why?
| | Models, Genetic | 1 | 2003 | 524 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2001 | 40 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2001 | 92 | 0.010 |
Why?
| | Cytoplasm | 1 | 2001 | 254 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1567 | 0.010 |
Why?
| | Etidronic Acid | 1 | 1999 | 3 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 1999 | 119 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2001 | 288 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 728 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 168 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1048 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2001 | 372 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22529 | 0.010 |
Why?
| | Cytokine Receptor gp130 | 1 | 1998 | 11 | 0.010 |
Why?
| | Skull | 1 | 1999 | 162 | 0.010 |
Why?
| | Osteocalcin | 1 | 1998 | 38 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 105 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 118 | 0.010 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 1998 | 41 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1310 | 0.010 |
Why?
| | Dexamethasone | 1 | 1999 | 365 | 0.010 |
Why?
| | RNA | 1 | 2003 | 910 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2001 | 693 | 0.010 |
Why?
| | Steroid Hydroxylases | 1 | 1996 | 19 | 0.010 |
Why?
| | Genitalia, Male | 1 | 1996 | 11 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1996 | 93 | 0.010 |
Why?
| | Sexual Maturation | 1 | 1996 | 48 | 0.010 |
Why?
| | Fibroblasts | 1 | 2001 | 1025 | 0.010 |
Why?
| | Antigens, CD | 1 | 1998 | 558 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1368 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1996 | 161 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1996 | 207 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 2105 | 0.010 |
Why?
| | Base Sequence | 1 | 1998 | 2170 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1999 | 1217 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1998 | 534 | 0.010 |
Why?
| | Amino Acids | 1 | 1998 | 519 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1246 | 0.010 |
Why?
| | Vagina | 1 | 1996 | 203 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1996 | 2524 | 0.000 |
Why?
| | Middle Aged | 1 | 2009 | 36215 | 0.000 |
Why?
|
|
Roberson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|